Gilead Sciences, Inc. 13D and 13G filings for Arcellx, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-28 09:13 am Sale | 2026-04-28 | 13D | ARCELLX INC ACLX | GILEAD SCIENCES INC. GILD | 100 100.000% | -6,720,703 (-100.00%) | Filing |
| 2026-02-23 06:51 am Unchanged | 2026-02-23 | 13D | ARCELLX INC ACLX | GILEAD SCIENCES INC. GILD | 6,720,803 11.500% | 0 (Unchanged) | Filing |
| 2023-12-28 5:06 pm Purchase | 2023-12-28 | 13G | ARCELLX INC ACLX | GILEAD SCIENCES INC. GILD | 6,720,803 12.900% | 3,242,542 (+93.22%) | Filing |
| 2023-02-06 4:05 pm Purchase | 2023-01-26 | 13G | ARCELLX INC ACLX | GILEAD SCIENCES INC. GILD | 3,478,261 7.300% | 3,478,261 (New Position) | Filing |